Skip to content

Facilitating Transition to Recommended PTSD Treatment

Improving Care for Veterans by Understanding and Facilitating Transition to Recommended PTSD Treatment (CDA 21-194)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05165940
Enrollment
40
Registered
2021-12-21
Start date
2026-12-01
Completion date
2027-05-03
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PTSD

Keywords

PTSD

Brief summary

Cognitive processing therapy (CPT) and prolonged exposure therapy (PE) were widely disseminated as recommended posttraumatic stress disorder (PTSD) treatments. However, post-9/11 Veterans with PTSD rarely initiate CPT or PE, especially as an initial treatment. Little research has explored the combinations and sequences of psychosocial and medication treatments that Veterans receive ("treatment sequences"). One common and understudied treatment sequence begins with stabilization treatment, which is designed to prepare Veterans for CPT or PE. There is a significant research gap in understanding how treatment sequence affects initiation of CPT or PE. The proposed research is an innovative, mixed-methods approach to assessing the impact of variability in treatment sequence, including stabilization treatment, on initiation of CPT or PE and applying this knowledge by developing a health services intervention that facilitates timely transition to CPT or PE. Research aims can improve PTSD treatment by increasing initiation of and reducing disparities in CPT/PE.

Detailed description

Posttraumatic stress disorder (PTSD) is one of the most common mental health diagnoses among Veterans. Cognitive processing therapy (CPT) and prolonged exposure therapy (PE) were widely disseminated in the Veterans Health Administration (VHA) as recommended PTSD treatments. Despite these efforts, few post-9/11 Veterans diagnosed with PTSD initiate CPT or PE. In the small percentage of Veterans who receive these therapies, CPT and PE are rarely the first treatment a Veteran receives. A common treatment sequence identified in implementation research, begins with "stabilization treatment," combinations of psychosocial and medication treatments that prepare Veterans for CPT or PE. Despite consistently identifying stabilization treatment as a common VHA practice, little research has investigated this treatment sequence. A novel approach to solving existing limitations in PTSD treatment delivery involves developing an intervention that both acknowledges the ubiquitous presence and benefits of stabilization treatment, while facilitating timely transition from stabilization treatment to CPT or PE. This CDA-2 aims to improve delivery of PTSD services in the VHA. The proposed research aims are: (1) To qualitatively understand Veterans' and clinicians' perspectives on selecting stabilization treatments and how stabilization treatment serves as a barrier or facilitator of transition to CPT or PE; (2) To develop and conduct a randomized, pragmatic pilot trial of a brief, Veteran-centered intervention to support transition from stabilization treatment to CPT or PE; and (3) To identify sociodemographic disparities in treatment sequences and to determine how treatment sequences influence time to CPT or PE initiation across the VHA.

Interventions

BEHAVIORALTreatment As Usual

Care Coordination Treatment as usual with a VA mental health treatment coordinator

BEHAVIORALNew Health Services Intervention

The experimental care coordination intervention begins with a 60-minute in-person session and continues with regular, brief contacts between the Veteran and clinician. During the first session, the clinician and Veteran will (1) discuss the Veteran's beliefs about their presenting problem; (2) collaboratively identify SMART goals; (3) discuss treatment options; (4) use shared decision-making to match treatment to SMART goals; (5) develop criteria to evaluate treatment progress; and (6) manage treatment expectations. During follow-up sessions, the clinician and Veteran will reflect on treatment progress, make appropriate updates to SMART goals, and re-evaluate barriers to CPT or PE.

Sponsors

VA Office of Research and Development
Lead SponsorFED
White River Junction Veterans Affairs Medical Center
CollaboratorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Participants will be randomized to receive care coordination as usual (i.e., TAU) through the VA or an experimental care coordination intervention.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Veteran * Diagnosed with PTSD as part of an intake assessment at the San Francisco Veterans Affairs Medical Center

Exclusion criteria

* Inability to provide informed consent * Cognitive impairment that precludes comprehension of study materials * Active psychosis

Design outcomes

Primary

MeasureTime frameDescription
Initiation of Recommended PTSD TreatmentThrough study completion, an average of 1 yearPatient self-report or documentation in the electronic health record of initiating either cognitive processing therapy (CPT) or prolonged exposure therapy (PE).

Secondary

MeasureTime frameDescription
Acceptability (Discontinuation of Mental Health Treatment without Provider Concurrence)Through study completion, an average of 1 yearPatient self-report or documentation in the electronic health record that a patient has discontinued all mental health treatment without provider concurrence.
Limited Efficacy Testing (PTSD Symptom Severity)Through study completion, an average of 1 yearSelf-Reported PTSD Symptom Severity as assessed by the PTSD Checklist for DSM-5.

Countries

United States

Contacts

CONTACTNicholas Holder, PhD
nicholas.holder@va.gov(415) 221-4810
PRINCIPAL_INVESTIGATORNicholas Holder, PhD

San Francisco VA Medical Center, San Francisco, CA

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026